Design, synthesis and evaluation of novel tacrine coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease

被引:151
作者
Xie, Sai-Sai [1 ]
Wang, Xiao-Bing [1 ]
Li, Jiang-Yan [1 ]
Yang, Lei [1 ]
Kong, Ling-Yi [1 ]
机构
[1] China Pharmaceut Univ, Dept Nat Med Chem, State Key Lab Nat Med, Nanjing 210009, Peoples R China
关键词
Alzheimer's disease; Coumarin; Tacrine; Metal chelator; Cholinesterase; beta-amyloid aggregation; AMYLOID-BETA-AGGREGATION; ACETYLCHOLINESTERASE INHIBITORS; BIOLOGICAL EVALUATION; DERIVATIVES; TARGET; POTENT; BUTYRYLCHOLINESTERASE; ANTIOXIDANT; HYPOTHESIS; CHELATOR;
D O I
10.1016/j.ejmech.2013.03.051
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of tacrine-coumarin hybrids (8a-t) were designed, synthesized and evaluated as multifunctional cholinesterase (ChE) inhibitors against Alzheimer's disease (AD). The screening results showed that most of them exhibited a significant ability to inhibit ChE and self-induced,beta-amyloid (A beta) aggregation, and to act as metal chelators. Especially, 8f displayed the greatest ability to inhibit acetylcholinesterase (AChE, IC50 = 0.092 mu M) and A beta aggregation (67.8%, 20 mu M). It was also a good butyrylcholinesterase inhibitor (BuChE, IC50 = 0.234 mu M) and metal chelator. Besides, kinetic and molecular modeling studies indicated that 8f was a mixed-type inhibitor, binding simultaneously to active, peripheral and mid-gorge sites of AChE. These results suggested that 8f might be an excellent multifunctional agent for AD treatment. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:540 / 553
页数:14
相关论文
共 53 条
  • [1] Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
    Amit, Tamar
    Avramovich-Tirosh, Yael
    Youdim, Moussa B. H.
    Mandel, Silvia
    [J]. FASEB JOURNAL, 2008, 22 (05) : 1296 - 1305
  • [2] A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease
    Anand, Preet
    Singh, Baldev
    Singh, Nirmal
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) : 1175 - 1180
  • [3] Metals in Alzheimer's and Parkinson's diseases
    Barnham, Kevin J.
    Bush, Ashley I.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) : 222 - 228
  • [4] Insight into the kinetic of amyloid β(1-42) peptide self-aggregation:: Elucidation of inhibitors' mechanism of action
    Bartolini, Manuela
    Bertucci, Carlo
    Bolognesi, Maria Laura
    Cavalli, Andrea
    Melchiorre, Carlo
    Andrisano, Vincenza
    [J]. CHEMBIOCHEM, 2007, 8 (17) : 2152 - 2161
  • [5] THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION
    BARTUS, RT
    DEAN, RL
    BEER, B
    LIPPA, AS
    [J]. SCIENCE, 1982, 217 (4558) : 408 - 417
  • [6] Multi-target-directed drug design strategy: From a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease
    Bolognesi, Maria Laura
    Cavalli, Andrea
    Valgimigli, Luca
    Bartolini, Manuela
    Rosini, Michela
    Andrisano, Vincenza
    Recanatini, Maurizio
    Melchiorre, Carlo
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (26) : 6446 - 6449
  • [7] Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-β aggregation
    Bolognesi, ML
    Andrisano, V
    Bartolini, M
    Banzi, R
    Melchiorre, C
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) : 24 - 27
  • [8] Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase
    Brühlmann, C
    Ooms, F
    Carrupt, PA
    Testa, B
    Catto, M
    Leonetti, F
    Altomare, C
    Carotti, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (19) : 3195 - 3198
  • [9] Bush AI, 2008, J ALZHEIMERS DIS, V15, P223
  • [10] Therapeutics for Alzheimer's disease based on the Metal Hypothesis
    Bush, Ashley I.
    Tanzi, Rudolph E.
    [J]. NEUROTHERAPEUTICS, 2008, 5 (03) : 421 - 432